These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 24439402)

  • 1. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
    Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
    Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral bioavailability of curcumin: problems and advancements.
    Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
    J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in studying curcumin and its nano-preparations for cancer therapy.
    Liu J; Chen S; Lv L; Song L; Guo S; Huang S
    Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application.
    Ma Z; Wang N; He H; Tang X
    J Control Release; 2019 Dec; 316():359-380. PubMed ID: 31682912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin and its formulations: potential anti-cancer agents.
    Ji JL; Huang XF; Zhu HL
    Anticancer Agents Med Chem; 2012 Mar; 12(3):210-8. PubMed ID: 22044005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art.
    Ahmad MZ; Alkahtani SA; Akhter S; Ahmad FJ; Ahmad J; Akhtar MS; Mohsin N; Abdel-Wahab BA
    J Drug Target; 2016; 24(4):273-93. PubMed ID: 26066739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic and Medicinal Prospective of Structurally Modified Curcumins.
    Kumar B; Singh V; Shankar R; Kumar K; Rawal RK
    Curr Top Med Chem; 2017; 17(2):148-161. PubMed ID: 27280465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer potential of curcumin: preclinical and clinical studies.
    Aggarwal BB; Kumar A; Bharti AC
    Anticancer Res; 2003; 23(1A):363-98. PubMed ID: 12680238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pharmaceutical nanoformulations for curcumin: Enhancement of aqueous solubility and carrier retention.
    Allijn IE; Schiffelers RM; Storm G
    Int J Pharm; 2016 Jun; 506(1-2):407-13. PubMed ID: 27139142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on Curcuma as a functional food in the control of cancer and inflammation.
    Schaffer M; Schaffer PM; Bar-Sela G
    Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin encapsulation in nanostructures for cancer therapy: A 10-year overview.
    D'Angelo NA; Noronha MA; Kurnik IS; Câmara MCC; Vieira JM; Abrunhosa L; Martins JT; Alves TFR; Tundisi LL; Ataide JA; Costa JSR; Jozala AF; Nascimento LO; Mazzola PG; Chaud MV; Vicente AA; Lopes AM
    Int J Pharm; 2021 Jul; 604():120534. PubMed ID: 33781887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in curcumin nanoformulation for cancer therapy.
    Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin nanomedicine: a road to cancer therapeutics.
    Yallapu MM; Jaggi M; Chauhan SC
    Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Design of Amphiphilic Polymeric Micelles of Curcumin for Cancer Management.
    Liu M; Du H; Zhai G
    Curr Med Chem; 2015; 22(38):4398-411. PubMed ID: 26714503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical applications of curcumin: current state and the future.
    Fan X; Zhang C; Liu DB; Yan J; Liang HP
    Curr Pharm Des; 2013; 19(11):2011-31. PubMed ID: 23116310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Applications of Curcumin Nanoformulations.
    Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
    AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubility enhancement and delivery systems of curcumin a herbal medicine: a review.
    Hani U; Shivakumar HG
    Curr Drug Deliv; 2014; 11(6):792-804. PubMed ID: 25176028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of curcumin and medicinal effects of the copper(II)-curcumin complexes.
    Leung MH; Harada T; Kee TW
    Curr Pharm Des; 2013; 19(11):2070-83. PubMed ID: 23116313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in nanotechnology-based delivery systems for curcumin.
    Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
    Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.